Form 4: STAAR Surgical Director Wei Jiang's RSU Vesting

STAAR Surgical Director Wei Jiang reported the vesting of 20,967 restricted stock units, increasing his direct beneficial ownership of common stock.

Summary

• Wei Jiang, a Director of STAAR Surgical Co. (STAA), reported the vesting of 20,967 restricted stock units (RSUs) on November 12, 2025.
• These RSUs converted into 20,967 shares of common stock, acquired at a price of $0 per share.
• Following this transaction, Mr. Jiang directly beneficially owns 45,477 shares of STAAR Surgical Co. common stock.
• This vesting represents the second of three tranches from an RSU award granted on May 12, 2025, in connection with Mr. Jiang's role as Chief of APAC Strategy and special strategic advisor.
• The remaining 20,967 RSUs are scheduled to vest on January 12, 2026.

Sentiment

Score: 6

Explanation: The filing reports a routine vesting of restricted stock units for a director, which increases their direct beneficial ownership, generally viewed as a neutral to slightly positive signal of alignment with shareholder interests.

Positives

• The vesting of restricted stock units increases a director's direct beneficial ownership, aligning their interests more closely with shareholders.

Future Outlook

The final 1/3 of the restricted stock units, totaling 20,967 shares, are scheduled to vest on January 12, 2026.

Management Comments

• Mr. Jiang serves as a special strategic advisor to the Corporation's Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy.

Industry Context

This Form 4 filing details an insider transaction, specifically the vesting of restricted stock units for a director, which is a routine event and does not inherently provide broad industry trend insights.

Related Party Transactions

• The restricted stock units were granted in connection with a consulting agreement for Mr. Jiang to serve as a special strategic advisor to the Corporation's Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy, as disclosed in a Form 8-K filed on April 24, 2025.

Stakeholder Impact

• Shareholders: Increased direct beneficial ownership by a director may signal continued alignment of interests with the company's performance.

Next Steps

• The final tranche of 20,967 restricted stock units is scheduled to vest on January 12, 2026.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled vesting of restricted stock units for a director. While it increases insider ownership, it does not reflect a discretionary purchase or sale that would typically alter the investment thesis for STAAR Surgical Co. Therefore, a 'hold' recommendation is appropriate as this event does not provide new fundamental information to warrant a change in existing positions.

Keywords

STAAR Surgical, STAA, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Ownership, Wei Jiang